Natco Pharma Q1 results: Profit falls 57% to ₹206 cr, revenue at ₹735 cr

The company had posted a consolidated net profit of ₹480.3 crore in the corresponding quarter last fiscal

Natco Pharma has reported a stark profit decline in the first quarter, largely driven by reduced sales of its leading cancer drug, lenalidomide. This led to a pronounced drop in consolidated revenues compared to the prior year. On a brighter note, the core business showed some…